Canada markets closed

Intellipharmaceutics International Inc. (IPCIF)

OTC Markets EXMKT - OTC Markets EXMKT Delayed Price. Currency in USD
Add to watchlist
0.15000.0000 (0.00%)
At close: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 4.96M
Enterprise Value 6.78M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)6.09
Price/Book (mrq)N/A
Enterprise Value/Revenue 7.49
Enterprise Value/EBITDA -1.08

Trading Information

Stock Price History

Beta (5Y Monthly) 0.45
52-Week Change 3101.34%
S&P500 52-Week Change 332.65%
52 Week High 30.1500
52 Week Low 30.0213
50-Day Moving Average 30.1500
200-Day Moving Average 30.0933

Share Statistics

Avg Vol (3 month) 3N/A
Avg Vol (10 day) 3N/A
Shares Outstanding 533.09M
Implied Shares Outstanding 690.83M
Float 832.51M
% Held by Insiders 11.76%
% Held by Institutions 10.00%
Shares Short (Feb 28, 2019) 4714k
Short Ratio (Feb 28, 2019) 40.39
Short % of Float (Feb 28, 2019) 43.35%
Short % of Shares Outstanding (Feb 28, 2019) 43.26%
Shares Short (prior month Jan 31, 2019) 4211.76k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 3�
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Sept 14, 2018
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Sept 14, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Nov 30, 2022
Most Recent Quarter (mrq)Aug 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-2,601.02%

Management Effectiveness

Return on Assets (ttm)-107.39%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)904.95k
Revenue Per Share (ttm)0.03
Quarterly Revenue Growth (yoy)260.40%
Gross Profit (ttm)N/A
EBITDA -2.41M
Net Income Avi to Common (ttm)-3.17M
Diluted EPS (ttm)-0.0900
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)400.1k
Total Cash Per Share (mrq)0.01
Total Debt (mrq)2.22M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.06
Book Value Per Share (mrq)-0.39

Cash Flow Statement

Operating Cash Flow (ttm)120.45k
Levered Free Cash Flow (ttm)1.07M